Valo's David Berry to Deliver Keynote at Founders Network's fnSummit 2022

Entrepreneuring Beyond the Headlines

BOSTON, MA (Octo­ber 7, 2022) — Valo Health, Inc (“Valo”), the tech­nol­o­gy com­pa­ny focused on trans­form­ing the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­gence, announced that David Berry, founder & CEO of Valo will deliv­er the keynote address at the Founders Net­work’s fnSum­mit 2022 where he will share his insights on what it takes to be a ser­i­al entrepreneur.

When you want to do some­thing with­out prece­dent, you have to have that will and that con­vic­tion. It’s about tak­ing what you want and mak­ing it so. But I firm­ly believe that is what we all signed up for and we have the oppor­tu­ni­ty to live the vision we are try­ing to cre­ate.“ — David Berry, founder & CEO, Valo Health

About Valo Health
Valo Health, Inc (“Valo”) is a tech­nol­o­gy com­pa­ny built to trans­form the drug dis­cov­ery and devel­op­ment process using human-cen­tric data and arti­fi­cial intel­li­gence dri­ven com­pu­ta­tion. As a dig­i­tal­ly native com­pa­ny, Valo aims to ful­ly inte­grate human-cen­tric data across the entire drug devel­op­ment life cycle into a sin­gle uni­fied archi­tec­ture, there­by accel­er­at­ing the dis­cov­ery and devel­op­ment of life-chang­ing drugs while simul­ta­ne­ous­ly reduc­ing costs, time, and fail­ure rates. The com­pa­ny’s Opal Com­pu­ta­tion­al Plat­form is an inte­grat­ed set of capa­bil­i­ties designed to trans­form data into valu­able insights that may accel­er­ate dis­cov­er­ies and enable Valo to advance a robust pipeline of pro­grams across car­dio­vas­cu­lar meta­bol­ic renal, oncol­o­gy, and neu­rode­gen­er­a­tive dis­ease. Found­ed by Flag­ship Pio­neer­ing and head­quar­tered in Boston, MA, Valo also has offices in Lex­ing­ton, MA, New York, NY, Bran­ford, CT, and San Fran­cis­co, CA. To learn more, vis­it www​.val​o​health​.com.